Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
It is currently the only compound of its kind that has received FDA approval (under the name Vyleesi) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, further highlighting its importance as a research molecule
it is intertwined and closely linked with multiple core metabolic pathways to jointly maintain the normal physiological functions of cells
Mechanisms of Ageing and Development (PubMed) (2004) 9
Over 422 million people globally have diabetes, significantly driving demand for GLP-1 analogues in metabolic disorder treatment and management
US$ 22.39
US$ 23.79
US$ 23.31
US$ 23.47
US$ 27.77
US$ 28.53
US$ 22.12
US$ 21.67
US$ 29.18
US$ 26.72
